Exane Derivatives’s The Bancorp TBBK Stock Holding History

Exane Derivatives’s Portfolio TBBK Stock Details TBBK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$83.7K	Sell	4,286 -530	-11%	-$11.4K	0.05%	280
2022 Q1	$136K	Sell	4,816 -4	-0.1%	-$115	0.04%	423
2021 Q4	$122K	Sell	4,820 -2,785	-37%	-$80.3K	0.03%	421
2021 Q3	$194K	Buy	7,605 +1,294	+21%	+$30.6K	0.05%	399
2021 Q2	$143K	Buy	6,311 +2,845	+82%	+$66.8K	0.03%	494
2021 Q1	$71.8K	Buy	+3,466	New	+$67.4K	0.02%	472
2019 Q2	–	Sell	-16,597	Closed	-$134K	–	713
2019 Q1	$134K	Sell	16,597 -2,195	-12%	-$19K	0.03%	265
2018 Q4	$150K	Hold	18,792	–	–	0.03%	281
2018 Q3	$180K	Sell	18,792 -790	-4%	-$7.99K	0.03%	258
2018 Q2	$207K	Buy	+19,582	New	+$215K	0.03%	263

Other funds holding TBBK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

OCM

Orchard Capital Management Chicago, Illinois $103M AUM 65.87% 1-Year Est. Return

Exane Derivatives's TBBK Position: Q2 2022 in Review

Exane Derivatives reduced its The Bancorp (TBBK) stake by 11% in Q2 2022, selling an estimated $11.4K and leaving 4,286 shares worth $83.7K. The position accounts for 0.05% of the portfolio, ranked #280.

Exane Derivatives first reported a position in TBBK in Q2 2018 and has held it in 10 quarters since. The position peaked at $207K in Q2 2018. 173 funds tracked by Wall St. Rank hold TBBK as of Q2 2022.

Exane Derivatives held 4,286 shares of The Bancorp worth $83.7K as of Q2 2022.
Exane Derivatives sold 530 The Bancorp shares in Q2 2022, an estimated $11.4K.
The Bancorp made up 0.05% of Exane Derivatives's portfolio in Q2 2022, its #280 holding.
Exane Derivatives first reported a position in The Bancorp in Q2 2018 and has held it in 10 quarters since.
Exane Derivatives's The Bancorp position peaked at $207K in Q2 2018.
173 funds tracked by Wall St. Rank held The Bancorp as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.